Same day dosing of pegfilgrastim in elderly patients receiving fractionated dose chemotherapy.

被引：0
|
作者：
Watt, LY
Redei, I
Levin, RD
Granick, J
Neelam, R
Musick, RE
机构：
[1] Canc Treatment Ctr Amer, Serv Pharm, Zion, IL USA
[2] CTCA, Stem Cell Transplant & Cell Therapy Unit, Zion, IL USA
[3] CTCA, Oncol Serv, Zion, IL USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2215.2215
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2215
引用
收藏
页码：609A / 609A
页数：1
相关论文
共 50 条
  • [21] Pegfilgrastim induces elevation of serum CA 15-3 in breast carcinoma patients after receiving dose-dense, adjuvant chemotherapy.
    Saura, C.
    Vilar, E.
    Cortes, J.
    Bellet, M.
    Ocana, A.
    Gomez, P.
    Baselga, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 491S - 491S
  • [22] Supportive care with pegfilgrastim improves neutropenic endpoints in patients receiving dose dense chemotherapy
    Andrews, C
    Garst, J
    Dunphy, F
    Blackwell, S
    Young, K
    Bjurstrom, T
    Crawford, J
    LUNG CANCER, 2005, 49 : S330 - S330
  • [23] Efficacy and safety of half-dose pegfilgrastim in cancer patients receiving cytotoxic chemotherapy
    Ramaekers, Ryan C.
    Olsen, Jon
    Obermiller, Angela Mae
    Jabbour, Melhem Salim
    Tharnish, Mark
    Schriner, Megan
    Hays, Rita
    Nelson, Deborah
    Benzel, Heather
    Hadenfeldt, Rebecca
    Fuller, Courtney
    Copur, Mehmet Sitki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Same day Pegfilgrastim and CHOP chemotherapy for non-Hodgkin lymphoma
    Lokich, Jacob J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 361 - 363
  • [25] Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen
    Rodolfo Mattioli
    Cesare Gridelli
    Javier Castellanos
    Antonio Duque
    Alfredo Falcone
    Mauro Mansutti
    Pam Bacon
    Sue Lawrinson
    Tomas Skacel
    J. Belon
    L. Estévez
    J. Mata
    A. Scanni
    Ana Casas
    Clinical and Translational Oncology, 2009, 11 : 842 - 848
  • [26] Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen
    Mattioli, Rodolfo
    Gridelli, Cesare
    Castellanos, Javier
    Duque, Antonio
    Falcone, Alfredo
    Mansutti, Mauro
    Bacon, Pam
    Lawrinson, Sue
    Skacel, Tomas
    Casas, Ana
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (12): : 842 - 848
  • [27] Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne, M
    Culakova, E
    Poniewierski, MS
    Wolff, D
    Dale, DC
    Crawford, J
    Lyman, GH
    BLOOD, 2005, 106 (11) : 874A - 874A
  • [28] Incidence of febrile neutropenia and effectiveness of pegfilgrastim prophylaxis in patients with advanced-stage solid tumors receiving chemotherapy.
    Crawford, Jeffrey
    Reiner, Maureen
    Morrow, Phuong Khanh H.
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Same day administration of pegfilgrastim with dose dense doxorubicin in early breast cancer patients.
    Vance, K. T.
    Carpenter, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 45S - 45S
  • [30] Pegfilgrastim in pediatric patients with sarcoma receiving intensive chemotherapy
    Spunt, SL
    Sender, L
    Santana, VM
    PEDIATRIC RESEARCH, 2003, 53 (04) : 290A - 290A
12345